E-Cigarette Liquids for Cardiopulmonary Health
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how e-cigarettes affect heart and lung health. Participants will use different types of tobacco-flavored e-liquid, such as Tobacco flavored liquid type 1 and Tobacco flavored liquid type 2, or abstain from e-cigarettes, to observe any changes in cardiopulmonary health. The trial seeks individuals who have used e-cigarettes at least three times a week for the past three months. Those who meet this criterion and wish to learn more about the health effects of e-cigarettes may find this trial suitable. As an Early Phase 1 trial, this research focuses on understanding the health impacts of e-cigarettes, offering participants a chance to contribute to groundbreaking insights.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but it excludes those using medications that affect heart and lung health.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that e-cigarettes, including those with tobacco-flavored liquids, contain harmful substances. Studies indicate that using these devices can slightly increase blood pressure and heart rate. For example, one review found a small rise in blood pressure (2 mm Hg) and heart rate (2 beats per minute) after using e-cigarettes with nicotine.
E-cigarettes also release potentially harmful chemicals that can affect the lungs and may raise the risk of lung problems. Notably, people who use both traditional cigarettes and e-cigarettes might face a higher risk of lung cancer than those who only smoke traditional cigarettes.
This trial is in its early stages and primarily aims to assess the safety of these e-cigarette liquids. Currently, there is limited safety data from users of these specific products. However, the early phase of the trial involves researchers evaluating how well participants tolerate these liquids.12345Why are researchers excited about this trial's treatments?
Most treatments for cardiopulmonary health issues focus on medication or lifestyle changes, but this trial is exploring the impact of different tobacco-flavored e-cigarette liquids. Researchers are excited because these e-liquids might offer a less harmful alternative for smokers, potentially reducing the negative effects on heart and lung health. Unlike standard nicotine replacement options, this study explores if variations in e-liquid composition can play a role in harm reduction for smokers, which could lead to new insights and options for improving cardiopulmonary health.
What evidence suggests that this trial's treatments could be effective for cardiopulmonary health?
This trial will compare the effects of two different e-cigarette liquids on cardiopulmonary health. Research has shown that e-cigarettes, even those with tobacco flavors, can help people quit smoking regular cigarettes, achieving better success rates than some other methods. However, no evidence suggests that e-cigarettes improve heart health. In fact, studies have linked e-cigarette use to blood vessel damage and increased oxidative stress, which can harm cells. Additionally, studies highlight various health risks, such as nicotine poisoning and possible lung damage. While e-cigarettes might assist in quitting smoking, their overall effects on heart and lung health remain unclear.26789
Who Is on the Research Team?
Paula Rodriguez Miguelez, PhD
Principal Investigator
Virginia Commonwealth University
Are You a Good Fit for This Trial?
This trial is for adults over the age of 21 who are either regular e-cigarette users (using them at least three times a week for more than three months) or those who have never used e-cigarettes. It's not specified, but typically people with certain health conditions may be excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use assigned e-cigarette products or abstain from use for 2 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Tobacco flavored liquid type 1
- Tobacco flavored liquid type 2
Trial Overview
The study is testing two types of tobacco-flavored liquids used in cartridge-based electronic cigarettes to see how they affect the heart and lungs of the users. Participants will use these liquids and their cardiopulmonary health will be monitored.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.
Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.
No e-cigarette use
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
Citations
Cardiopulmonary Impact of Electronic Cigarettes and ...
Vaping can cause a wide array of severe adverse health effects that include nicotine poisoning, trauma from device battery explosions, and injury to the ...
E-cigarettes and cardiopulmonary health: A review for clinicians
In clinical trials, use of electronic cigarettes improves smoking cessation rates (OR = 1.529 [95% CI: 1.158 to 2.019]) compared to conventional therapies.
Electronic Nicotine Delivery Systems and Cardiovascular
Vanilla and tobacco flavored e-cig liquids showed a greater overall increase in ROS levels than apple/mint flavored e-liquid. Vanilla and ...
Electronic cigarette use, related health outcomes and ...
E-cigarette use is associated with several adverse acute health outcomes; there is currently insufficient longitudinal evidence to predict chronic health ...
5.
truthinitiative.org
truthinitiative.org/research-resources/emerging-tobacco-products/e-cigarettes-facts-stats-and-regulationsE-cigarettes: Facts, stats and regulations
To date, there is no available evidence to suggest that e-cigarette use is associated with clinical cardiovascular outcomes such as coronary heart disease, ...
Pulmonary effects of e-liquid flavors: a systematic review
The aim of this review was to assess evidence from 38 reports on the adverse effects of flavored e-liquids on the respiratory system in both in vitro and in ...
Health Risks of E-Cigarettes and Vaping
Using e-cigarettes causes health risks. It concluded that e-cigarettes both contain and emit a number of potentially toxic substances.
8.
hopkinsmedicine.org
hopkinsmedicine.org/health/wellness-and-prevention/what-does-vaping-do-to-your-lungsWhat Does Vaping Do to Your Lungs?
Many people wonder if vaping is bad for your lungs. Find out from an expert how it impacts lungs and which illnesses are associated with vaping.
E-Cigarettes and Cardiopulmonary Health - PMC
As discussed before, nicotine levels are ∼50-fold lower in plasma after use of e-cigarettes, snus, or tobacco than in the lung after tobacco or e-cigarette ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.